Tag: Samsung BioLogics

Samsung BioLogics

Latest News

Samsung Biologics plans 3 trillion won capital increase to fund PolyPeptide Group deal

The rights offering aims to accelerate the company’s push to become a world-leading contract development and manufacturing organization, Samsung Biologics said.

2026.8.28

Samsung Biologics Q2 net rises on full-capacity operations, weak won

Samsung Biologics posted a 29.1 percent rise in second-quarter net profit as full-capacity plant operations, expanding production and a weak won lifted earnings.

2026.7.23

Most popular

Samsung Biologics set for largest Korean pharma M&A with $1.8B PolyPeptide deal

The acquisition expands the company's portfolio into peptide-based medicines central to the booming weight loss drug industry.

2026.7.20

Samsung Biologics launches record $1.8 billion bid for PolyPeptide, targeting obesity drug market

The 2.7 trillion won acquisition gives Samsung Biologics a major foothold in peptide manufacturing and the fast-growing obesity and diabetes drug market.

2026.7.20

Samsung Biologics union votes to leave pan-affiliate labor coalition

Workers backed an independent structure as pay disputes and widening rifts weaken Samsung Group United Union.

2026.6.28

The Samsung Biologics factory in Yeonsu District, Incheon, on the morning of May 1, the first day of the union's full strike [YONHAP]

Samsung Biologics, union to return to direct negotiations, but concerns grow of prolonged dispute

Though Samsung Biologics and its labor union, which failed to reach an agreement despite government mediation, have decided to return to direct negotiations, signs are emerging that the dispute could be prolonged as their legal battle intensifies.

2026.5.29

A person is seen in front of Samsung Biologics headquarters in Songdo, Incheon, on May 6. [NEWS1]

Police raid Samsung Biologics over alleged leak of confidential documents by union leader

Police raided Samsung Biologics headquarters to investigate allegations that a union leader had leaked confidential corporate documents, the law enforcement authority said on Wednesday.

2026.5.27

Samsung Biologics' offices in Yeonsu District, Incheon [YONHAP]

Unionized members of Samsung Biologics return with work-to-rule campaign

Unionized workers of Samsung Biologics returned to work Wednesday after a five-day walkout, but have decided to continue talks with the company under a work-to-rule campaign, the union said.

2026.5.6

The entrance to the Samsung Biologics facility in Songdo, Incheon, on May 4. [KIM KYOUNG-ROK]

Samsung Biologics strike continues as talks with union break down despite government mediation

Talks between Samsung Biologics and its union broke down on Monday despite government mediation, raising the risk of a prolonged strike that has already caused losses of 150 billion won ($101 million).

2026.5.4

Union flags are seen hung up near the entrance of a Samsung Biologics plant in Yeonsu District, Incheon, on April 30. [YONHAP]

Samsung Biologics strike escalates as union demands role in hiring, personnel evaluations, M&As

Tensions are escalating at Samsung Biologics beyond wage negotiations into a clash over management control, as the union demands a role in key corporate decisions, including hiring, personnel evaluations and mergers and acquisitions (M&As).

2026.5.3